Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint
| Image |  |
|---|---|
| Description | article |
| Author/s |
author: Eric A Macklin Gary R. Cutter |
| Publication date | June 7, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |